Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 3:45 p.m.

    📋 Kezar Life Sciences, Inc. (KZR) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 16:08:12

    Event Type: Financial Results

    Event Details:

    Kezar Life Sciences Inc (KZR) Reports Q2 2022 Financial Results Kezar Life Sciences Inc (KZR) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $ 242,609
      • expected in June 2022
      • targeting the Sec61 translocon and the protein secretion pathway. An open-label dose-escalation Phase 1 clinical trial of KZR-261 to assess safety, tolerability and preliminary tumor activity in solid tumors is underway. For more information, visit www.kezarlifesciences.com. Cautionary Note on Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    In Thousands Cash Equivalents Marketable Securities 242.61K 208.35K $34.25K +16.44%
    Operating Expenses Loss From Operations -15.88K -13.05K $-2.83K -21.69%
    Operating Expenses Interest Income 108.00 54.00 $54.00 +100.00%
    Operating Expenses Net Loss -16.02K -12.99K $-3.03K -23.32%
    Operating Expenses Net Loss Per Share -0.26 -0.25 $-0.01 -4.00%
    Operating Expenses Weighted Average Shares 60.63M 51.06M $9.57M +18.75%
    Cash and Marketable Securities 242.61K 242.61K $0.00 +0.00%
    Loss from Operations -15.88K -13.05K $-2.83K -21.69%
    Interest Income 108.00 54.00 $54.00 +100.00%
    Net Loss -16.02K -12.99K $-3.03K -23.32%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Kezar Life Sciences Inc
    • CIK: 0001645666
    • Ticker Symbol: KZR
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories